Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Taslim Najla"'
Autor:
Abbott Derek J, Blanchfield J Lori, Martinson David A, Russell Sean C, Taslim Najla, Curtis Alan D, Mannie Mark D
Publikováno v:
BMC Immunology, Vol 12, Iss 1, p 72 (2011)
Abstract Background Vaccination strategies that elicit antigen-specific tolerance are needed as therapies for autoimmune disease. This study focused on whether cytokine-neuroantigen (NAg) fusion proteins could inhibit disease in chronic murine models
Externí odkaz:
https://doaj.org/article/cf90aa1021ef42a7980739a8a6cc1177
Autor:
Taslim, Najla1 ntakbar@iau.edu.sa, Alghamdi, Amal Turikham2, Alqarni, Dana Ali3, Rashid, Shaista4, Edge, Dustin Todd5
Publikováno v:
Medicinski Glasnik. Feb2024, Vol. 21 Issue 1, p168-174. 9p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Behavioural Brain Research 1 March 2011 217(2):282-292
Autor:
Taslim, Najla, Canales, Arthur D.
Publikováno v:
Journal of Gender, Culture & Society; 2023, Vol. 3 Issue 1, p6-18, 13p
Publikováno v:
Psychiatria Danubina
Volume 33
Issue broj 4
Volume 33
Issue broj 4
Gender dysphoria (GD)-perceived gender identity and the biological sex has been a wholly enigma and a source of contention bet
Autor:
Ezeamuzie, Charles I., Taslim, Najla
Publikováno v:
In European Journal of Pharmacology 2006 543(1):174-180
Autor:
Curtis II, Alan D.1,2, Taslim, Najla1,2, Reece, Shaun P.3, Grebenciucova, Elena1,4, Ray, Richard H.3, Rosenbaum, Matthew D.5, Wardle, Robert L.3, Van Scott, Michael R.3, Mannie, Mark D.1,2 manniem@ecu.edu
Publikováno v:
PLoS ONE. Oct2014, Vol. 9 Issue 10, p1-17. 17p.
Autor:
Ezeamuzie, Charles I.1 ezeamuzie@hsc.edu.kw, Taslim, Najla1
Publikováno v:
British Journal of Pharmacology. Nov2004, Vol. 143 Issue 6, p725-732. 8p.
Autor:
Ezeamuzie, Charles I, Taslim, Najla
The mechanism of inhibition of eosinophil degranulation by protein kinase C (PKC) was investigated in complement C5a (C5a)-stimulated degranulation of highly purified human eosinophils using the specific PKC activator - phorbol 12-myristate 13-acetat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7710d0602f1796350e0240f69903121d
https://europepmc.org/articles/PMC1575935/
https://europepmc.org/articles/PMC1575935/